首页> 美国卫生研究院文献>Journal of the Royal Society of Medicine >Twice-daily insulin regimens in management of severe diabetes.
【2h】

Twice-daily insulin regimens in management of severe diabetes.

机译:每天两次胰岛素治疗严重糖尿病。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Diurnal glucose profiles have been compared in ten insulin dependent diabetics receiving, firstly, a twice-daily soluble insulin (SI): isophane insulin (NPHI) insulin (30% SI, 70% NPHI). For each patient the two regimens gave similar profiles though nocturnal blood glucose control was better on Mixtard. HbA1 values were similar on the two regimens. The findings show that, using highly purified formulations, small changes in insulin proportions in twice-daily SI: NPHI regimens may be irrelevant to diabetic control; they also suggest that highly purified NPHI may have a substantially shorter duration of action than its older counterpart and that the convenient regimen of twice-daily Mixtard is usually as good as any more complicated 'tailormade' regimen of highly purified insulins.
机译:在十个胰岛素依赖型糖尿病患者中,首先接受每日两次可溶的胰岛素(SI):异戊烷胰岛素(NPHI)胰岛素(30%SI,70%NPHI),比较了每日的葡萄糖谱。对于每位患者,尽管在Mixtard上夜间血糖控制效果更好,但两种方案的情况相似。两种方案的HbA1值相似。研究结果表明,使用高度纯化的制剂,每天两次的SI:NPHI方案中胰岛素比例的细微变化可能与糖尿病控制无关。他们还表明,高纯度的NPHI可能比其较早的同类药物具有更短的作用时间,而且每日两次Mixtard的便捷方案通常与任何更复杂的高纯度胰岛素的“量身定制”方案一样好。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号